75.66
1.46 (1.97%)
1.46 (1.97%)
Upgrade to Real-Time
Afterhours (Closed)
Low
61.53
High
75.8601
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NVO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.46 | 1.97% | 75.66 | 17:15:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 75.04 | 75.04 | 75.78 | 75.66 | 74.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,825 | 746,188 | $ 75.56 | $ 56,378,249 | 804,664 | 61.53 - 75.8601 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 15,545 | $ 75.66 | USD |
Novo Nordisk Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 174.39B | 2.30B | 2.30B | $ 20.84B | $ 6.79B | 2.96 | 25.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.40 | 1.85% | - | - |
Novo Nordisk News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 74.01 | 75.78 | 73.53 | 74.35 | 1,080,255 | 1.65 | 2.23% |
| 1 Month | 70.03 | 75.78 | 69.29 | 73.13 | 864,477 | 5.63 | 8.04% |
| 3 Months | 73.90 | 75.8601 | 66.59 | 71.77 | 932,729 | 1.76 | 2.38% |
| 6 Months | 67.05 | 75.8601 | 65.70 | 70.77 | 999,815 | 8.61 | 12.84% |
| 1 Year | 63.19 | 75.8601 | 61.53 | 68.55 | 1,068,488 | 12.47 | 19.73% |
| 3 Years | 47.80 | 75.8601 | 41.229 | 55.96 | 1,401,661 | 27.86 | 58.28% |
| 5 Years | 54.91 | 75.8601 | 30.89 | 49.34 | 1,718,340 | 20.75 | 37.79% |
Novo Nordisk Description
| With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. |
